SCHEMBL25035986

SCHEMBL25035986

c1ccc(-c2nc(-c3cccc(-c4ccc(-c5cccc6c5C5(c7cc8ccccc8cc7-6)C6CC7CC(C6)CC5C7)cc4)c3)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
NR2E1 Q9Y466 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GP6 Q9HCN6 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
ADORA1 P30542 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
HSD11B1 P28845 1/20 0.31
HTT P42858 1/20 0.31
MAPT P10636 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25037917 0.97 GP6 (0.33) MEN1KMT2AALDH1A1KDM4ETHRB
SCHEMBL25038117 0.93 HTT (0.33) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL25037653 0.89 MEN1 (0.36) MEN1KMT2AALDH1A1KDM4ETHRB
SCHEMBL25037726 0.89 TAAR1 (0.34) HSD11B1
SCHEMBL25035880 0.87 PDE7A (0.34) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL25036031 0.87 MEN1 (0.32) MEN1KMT2AALDH1A1KDM4ETHRB
SCHEMBL25035956 0.86 GP6 (0.35) MEN1KMT2AALDH1A1KDM4ETHRB
SCHEMBL25035952 0.86 MEN1 (0.36) MEN1KMT2AALDH1A1KDM4ETHRB
SCHEMBL25038131 0.86 GP6 (0.35) MEN1KMT2AALDH1A1KDM4ETHRB
SCHEMBL25038223 0.86 MEN1 (0.36) MEN1KMT2AALDH1A1KDM4ETHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-04 US disclosed
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-04 US disclosed
US-20230052660-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230052660-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NOD1, NFE2L2, NOTCH1 MEN1 1265/4885KMT2A 1223/4885ALDH1A1 3460/4885
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same NOD1, NFE2L2, NOTCH1 MEN1 1265/4885KMT2A 1223/4885ALDH1A1 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.